VerMais Glaucoma Sector

VerMais is a Brazilian healthtech company specializing in the early detection and monitoring of glaucoma through artificial intelligence and digital health solutions. The company's primary offering is a software platform that utilizes advanced algorithms to analyze retinography and optical coherence tomography (OCT) images, providing clinicians with automated screening tools to identify signs of glaucomatous damage. By integrating AI into the ophthalmic workflow, VerMais aims to increase the accessibility of eye care and prevent irreversible vision loss in high-risk populations. Their services are primarily utilized by eye clinics and diagnostic centers to enhance diagnostic accuracy and patient management efficiency.